Pharma Mar (PHMMF) Raised to “Hold” at Zacks Investment Research .

PharmaMar (OTCMKTS:PHMMF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports.